2000
DOI: 10.1067/mtc.2000.106327
|View full text |Cite
|
Sign up to set email alerts
|

Clinical experience with autologous endothelial cell–seeded polytetrafluoroethylene coronary artery bypass grafts

Abstract: Patency of autologous endothelial cell-seeded 4-mm polytetrafluoroethylene vascular prostheses as coronary artery bypass grafts was much better than that of unseeded polytetrafluoroethylene grafts. Further evaluations and a larger population of patients will prove whether the encouraging patency will last.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
73
0
2

Year Published

2001
2001
2014
2014

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 137 publications
(79 citation statements)
references
References 22 publications
1
73
0
2
Order By: Relevance
“…20 Using the 2-stage "sodding" technique has improved clinical results, but requires long-term endothelial cell culture (4 to 6 weeks). 21,22 A second obstacle in endothelialization of grafts is the poor retention of seeded cells. Human endothelial cells show little adhesion to the currently available vascular graft materials.…”
Section: Discussionmentioning
confidence: 99%
“…20 Using the 2-stage "sodding" technique has improved clinical results, but requires long-term endothelial cell culture (4 to 6 weeks). 21,22 A second obstacle in endothelialization of grafts is the poor retention of seeded cells. Human endothelial cells show little adhesion to the currently available vascular graft materials.…”
Section: Discussionmentioning
confidence: 99%
“…[6][7][8] Over the past 50 years, clinical studies have indicated that the endothelial cells (ECs)-seeded grafts have high patency rate in human cardiac artery and lower extremity artery bypass grafting. 9,10 Despite such successful results, the clinical application of the ECs-seeded graft was still hampered by the lack of a convenient source of ECs. 11 During the last decade, fortunately, the discovery of endothelial progenitor cells (EPCs) has opened up vistas to possible TEVGs with these cells.…”
Section: Introductionmentioning
confidence: 99%
“…So far, many researchers have described seeding endothelial cells in conduits. A recent study reported a patency rate of 90% in 27 months for ePTFE prostheses used in coronary bypass, after additional incubation with endothelial cells which allowed them to adhere to the material (Laube HR et al 2000). The major limitation of this method is the need for cell cultures and withdrawal of tissue from the patient, and in any case it remains a two-step procedure.…”
Section: Materials Surfacementioning
confidence: 99%